Health ministry decides against including Itolizumab in clinical management protocols for COVID-19
The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.